Image courtesy of InterValve
January 28, 2015 — Maquet Medical Systems USA announced an agreement to serve as the exclusive U.S. distributor of InterValve Inc.'s V8 Aortic Valvuloplasty Balloon Catheter. The V8 catheter is designed to be used in stand-alone balloon aortic valvuloplasty (BAV) and pre-dilatation during transcatheter aortic valve replacement (TAVR) procedures. Maquet's sales representatives in the United States will begin selling the V8 catheter during the first quarter of 2015.
The V8 balloon catheter is designed to inflate and deflate rapidly to reduce the duration of blood flow obstruction across the valve and features a "figure-8" shape balloon that enables the bulbs at either end of the balloon to lock into either side of the aortic annulus. This design has the potential to reduce the risk of balloon movement during dilatation. The V8 is the first ever valvuloplasty catheter that maintains the figure-8 shape throughout inflation, which allows for leaflet hyper-extension to create maximum valve area opening, without increasing the risk of overstretching the annulus. The product received 510(k) clearance in February 2014.
Raoul Quintero, president and CEO Maquet North America said, "We're seeing our customers look to BAV and TAVR as alternatives to surgical aortic valve replacement. In particular, technology improvements, operator and team experience and continued research have resulted in increased interest and growth in transcatheter aortic valve replacement."
For more information: www.maquet.com, www.intervalveinc.com
June 13, 2024 
